Description: Yield10 Bioscience, Inc., an agricultural bioscience company, engages in developing technologies to enable step-change increases in crop yield in the United States and Canada. The company, through its Trait Factory, a trait gene discovery platform develops enhanced oilseed Camelina sativa for the production of proprietary seed products; and discovers high value genetic traits for the agriculture and food industries. Yield10 Bioscience, Inc. has license agreements with GDM Seeds; J. R. Simplot; Forage Genetics International, LLC; and Bayer AG. The company was formerly known as Metabolix, Inc. and changed its name to Yield10 Bioscience, Inc. in January 2017. Yield10 Bioscience, Inc. was incorporate in 1992 and is headquartered in Woburn, Massachusetts.
Home Page: www.yield10bio.com
19 Presidential Way
Woburn,
MA
01801
United States
Phone:
617 583 1700
Officers
| Name | Title |
|---|---|
| Dr. Oliver P. Peoples | Co-Founder, Pres, CEO & Director |
| Dr. Anthony J. Sinskey Ph.D., Sc.D. | Co-Founder & Independent Director |
| Dr. Kristi D. Snell | VP of Research & Chief Science Officer |
| Ms. Lynne H. Brum | VP of Planning & Corp. Communications and Sec. |
| Mr. Charles B. Haaser | VP of Fin., Chief Accounting Officer & Treasurer |
| Dr. Nicholas Renegar Ph.D. | Director of Bus. Analytics & Operations |
Exchange: F
Country: DE : Germany
Currency: Euro (€)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 1.1404 |
| Price-to-Sales TTM: | 17.1939 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 29 |